186 related articles for article (PubMed ID: 7654116)
1. Empiric therapy for gastroesophageal reflux disease.
Schindlbeck NE; Klauser AG; Voderholzer WA; Müller-Lissner SA
Arch Intern Med; 1995 Sep; 155(16):1808-12. PubMed ID: 7654116
[TBL] [Abstract][Full Text] [Related]
2. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Fiorucci S; Santucci L; Morelli A
Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
4. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
Katzka DA; Paoletti V; Leite L; Castell DO
Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
[TBL] [Abstract][Full Text] [Related]
6. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
[TBL] [Abstract][Full Text] [Related]
7. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
[TBL] [Abstract][Full Text] [Related]
8. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
Ours TM; Kavuru MS; Schilz RJ; Richter JE
Am J Gastroenterol; 1999 Nov; 94(11):3131-8. PubMed ID: 10566703
[TBL] [Abstract][Full Text] [Related]
9. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease.
Hillman AL; Bloom BS; Fendrick AM; Schwartz JS
Arch Intern Med; 1992 Jul; 152(7):1467-72. PubMed ID: 1627026
[TBL] [Abstract][Full Text] [Related]
10. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
[TBL] [Abstract][Full Text] [Related]
11. Omeprazole as a diagnostic tool in gastroesophageal reflux disease.
Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Jansen EH; Tuynman HA; Schrijver M; Dieleman LA; Meuwissen SG
Am J Gastroenterol; 1997 Nov; 92(11):1997-2000. PubMed ID: 9362179
[TBL] [Abstract][Full Text] [Related]
12. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
[TBL] [Abstract][Full Text] [Related]
13. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.
Dettmar PW; Sykes J; Little SL; Bryan J
Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641
[TBL] [Abstract][Full Text] [Related]
14. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.
Tefera S; Hatlebakk JG; Berstad A
Am J Gastroenterol; 2001 Apr; 96(4):969-74. PubMed ID: 11316213
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy of gastroesophageal reflux (a prospective controlled clinical trial)].
Wittmann T; Rosztóczy A; Fehér A; Jármay K; Oláh T; Szendrényi V; Kiss I
Orv Hetil; 1998 May; 139(18):1077-81. PubMed ID: 9608770
[TBL] [Abstract][Full Text] [Related]
16. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.
Størdal K; Johannesdottir GB; Bentsen BS; Knudsen PK; Carlsen KC; Closs O; Handeland M; Holm HK; Sandvik L
Arch Dis Child; 2005 Sep; 90(9):956-60. PubMed ID: 16113133
[TBL] [Abstract][Full Text] [Related]
17. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
18. Pharyngolaryngeal reflux in outpatient clinical practice: personal experience.
Galli J; Scarano S; Agostino S; Quaranta N; Cammarota G; Ottaviani F
Acta Otorhinolaryngol Ital; 2003 Feb; 23(1):38-42. PubMed ID: 12812134
[TBL] [Abstract][Full Text] [Related]
19. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
Omari TI; Haslam RR; Lundborg P; Davidson GP
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
[TBL] [Abstract][Full Text] [Related]
20. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
